US FDA approves new effective antimalarial treatment in a single dose



[ad_1]

U.S. FDA Approves New Effective Treatment of Malaria in One Dose

July 27, 2018

CNBC: CEO of Gates Foundation: FDA Approval of Single Dose Drug to Fight Malaria
"Sue Desmond-Hellman, CEO of the Gates Foundation the importance of a new drug, Krintafel (tafenoquine), which offers the hope of a radical cure for malaria. Also Desmond-Hellman shares his thoughts on preparing for the next pandemic threat … "(7/27).

NPR: New drug eliminates malaria in a single dose – But there is a hitch
"… On Friday, the US Food and Drug Administration approved a drug to cure a type of Malaria hard to stop Called Plasmodium vivax, the parasite can hide in a person's liver for months and cause several malaria even after being treated … But there is just one big problem: for Use tafenoids, doctors and nurses need a sophisticated test that is not available in many poor places.In some people, tafenoquine can break the red blood cells and die. people can become anemic, and in some cases it can be fatal … "(Doucleff, 7/26).

[ad_2]
Source link